Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Wealth building strategies for young adults are essential. Discover ways to grow your wealth and achieve financial goals.
15,504 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This guide breaks down what to watch in Jackson Financial's 2025 earnings, with practical tips and real-world scenari...
A federal court in Tennessee blocked state enforcement actions against Kalshi, citing a likelihood the contracts may ...
Southwest Airlines is rolling out a new boarding system that is drawing complaints about overhead-bin squeezes and lo...
A pivotal license extension in Ghana fuels a surge in Kosmos Energy. This article breaks down what the move means for...
U.S. spot Bitcoin ETFs logged a fifth straight week of net withdrawals, signaling cooling institutional demand amid a...
A quarterly data snapshot reveals moves by the wealthiest fund managers. This piece dives into why these billionaire ...
Virginia-based City Lending Inc. is winding down operations as regulators tighten oversight and the mortgage market c...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
This article breaks down Quaker Chemical's Q4 2025 earnings implications, real-world drivers, and practical steps you...
Keystone Financial makes a bold move by loading into a free cash flow ETF, signaling a focus on durable cash generati...
The Trade Desk prepares to report quarterly results as investors grapple with a steep stock drop, focusing on revenue...